Efficacy and safety of Tianmabianchunzhigan in mild to moderate vascular dementia: Protocol of a randomized controlled IIa trial

BACKGROUND: Vascular dementia (VaD) is the 2nd most common subtype of dementia after Alzheimer disease. Currently, there are no medications approved for treating patients with VaD. Tianmabianchunzhigan (TMBCZG) tablet is an active ingredient extracted from Gastrodia that has been reported to improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Jinzhou, Shi, Jing, Wei, Mingqing, Li, Ting, Ni, Jingnian, Zhang, Xuekai, Zhang, Meng, Li, Yang, Wang, Yongyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319825/
https://www.ncbi.nlm.nih.gov/pubmed/30572524
http://dx.doi.org/10.1097/MD.0000000000013760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319825/
https://www.ncbi.nlm.nih.gov/pubmed/30572524
http://dx.doi.org/10.1097/MD.0000000000013760

Ejemplares similares